Objective: The aim of the present study was to investigate the effects of a 6 month gemfibrozil treatment.
Subjects: A sample of 64 visceral obese men (age 46+/-6 y; body mass index 31+/-3 kg/m(2); waist circumference 104+/-7 cm; mean+/-s.d.) who received dietary recommendations.
Methods: Subjects were randomly assigned to receive a placebo (n=32) or gemfibrozil (1200 mg/day) (n=32).
Results: In both placebo and gemfibrozil treated groups, significant reductions were noted in body weight, fat mass, waist circumference and visceral adipose tissue area measured by computed tomography (0.0001
Download full-text PDF
Source
http://dx.doi.org/10.1038/sj.ijo.0801665 DOI Listing Publication Analysis
Top Keywords
Similar Publications
Clinical and molecular characterization of familial chylomicronemia in Saudi patients: a retrospective study.
Front Endocrinol (Lausanne)
December 2024
Department of Pediatrics, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Article Synopsis
- - Familial chylomicronemia syndrome (FCS) is a rare but severe form of hypertriglyceridemia, with over 100 cases identified at a specific center aimed at supporting clinicians and enhancing knowledge in disease management.
- - A study of 29 pediatric patients revealed common symptoms such as milky blood samples, family history of hypertriglyceridemia, and acute pancreatitis, with gemfibrozil and fenofibrate proving effective in lowering triglyceride levels.
- - The findings suggest anti-triglyceride medications, particularly fibrates, are safe and effective in managing FCS in kids, with gemfibrozil showing superior results compared to fenofibrate and both drugs causing minimal side effects
Six-year follow-up of a child with familial chylomicronemia syndrome: disease course and effectiveness of gemfibrozil treatment --case report and literature review.
Ann Pediatr Endocrinol Metab
April 2024
Al Jalila Children's Hospital, Dubai, UAE.
Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disease affecting lipoprotein metabolism. FCS is estimated to occur in 1 in 1-2 million individuals and can be diagnosed at any age, equally affecting all genders, races, and ethnicities. The condition is characterized by hypertriglyceridemia, which may predispose patients to acute pancreatitis.
View Article and Find Full Text PDFThe impact of the duration of the integrated disease management program on COPD-related outcomes.
Eur J Med Res
May 2023
Big Data Center, Changhua Christian Hospital, Changhua, 500, Taiwan.
Background: The aim of this study is to assess the impact of the duration of the integrated disease management (IDM) program on COPD-related outcomes in real-world setting.
Methods: A retrospective cohort study among 3771 patients with COPD who had regularly completed 4 visits of IDM program within 1 year between April 1, 2017 and December 31, 2018. CAT score as the primary outcome used to investigate the association between IDM intervention duration and improvement in CAT score.
Association of plasma metabolites and diagnostic imaging findings with hepatic lipidosis in bearded dragons (Pogona vitticeps) and effects of gemfibrozil therapy.
PLoS One
October 2023
Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
Objectives: To evaluate the association between plasma metabolites, biochemical analytes, diagnostic imaging findings, and the histologic diagnosis of hepatic lipidosis in bearded dragons. To assess the effects of gemfibrozil therapy on hepatic lipid accumulation and associated diagnostic tests.
Animals: Fourteen bearded dragons (Pogona vitticeps) with varying severity of hepatic lipid accumulation (with and without hepatic lipidosis) were included.
Acute pancreatitis following COVID-19 vaccine: A case report and brief literature review.
Heliyon
January 2023
Department of Anesthesiology and Critical Care Medicine, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
Vaccination is the most effective way to overcome COVID-19 morbidity and mortality. However, Covid-19 vaccines may cause potential adverse effects. We reported a 28-year-old healthy woman who was referred to the emergency department with a chief complaint of severe abdominal pain, nausea and hemoptysis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!